Showing results (151-160 of 248) with videos related to

Sort By:
Pageof 25
Rheumatology and Therapy|October 5, 2023
Targeting DORIS Remission and LLDAS in SLE: A ReviewAgner R Parra Sánchez, Ronald F van Vollenhoven, Eric F Morand, et al.
Cytokine|February 4, 2015
Macrophage migration inhibitory factor is essential for osteoclastogenic mechanisms in vitro and in vivo mouse model of arthritisRan Gu, Leilani L Santos, Devi Ngo, et al.
Arthritis Research & Therapy|July 29, 2006
Macrophage migration inhibitory factor: a mediator of matrix metalloproteinase-2 production in rheumatoid arthritisAngela Pakozdi, Mohammad A Amin, Christian S Haas, et al.
Rheumatology (Oxford, England)|February 6, 2021
Safety and clinical activity of atacicept in the long-term extension of the phase 2b ADDRESS II study in systemic lupus erythematosusDaniel J Wallace, David A Isenberg, Eric F Morand, et al.
Development (Cambridge, England)|August 22, 2018
GILZ-dependent modulation of mTORC1 regulates spermatogonial maintenanceHue M La, Ai-Leen Chan, Julien M D Legrand, et al.
International Immunopharmacology|June 8, 2018
Formyl peptide receptor activation inhibits the expansion of effector T cells and synovial fibroblasts and attenuates joint injury in models of rheumatoid arthritisDragana Odobasic, Yuan Jia, Wenping Kao, et al.
Annals of the Rheumatic Diseases|February 13, 2025
LLDAS and remission attainment with anifrolumab treatment in patients with systemic lupus erythematosus: results from the TULIP and long-term extension randomised controlled trialsEric F Morand, Ronald van Vollenhoven, Richard A Furie, et al.
ACR Open Rheumatology|September 15, 2023
Identifying lupus Patient Subsets Through Immune Cell Deconvolution of Gene Expression Data in Two Atacicept Phase II StudiesMatthew Studham, Cristina Vazquez-Mateo, Eileen Samy, et al.
Frontiers in Immunology|October 7, 2015
Transcriptional Enhancers in the Regulation of T Cell DifferentiationMichelle L T Nguyen, Sarah A Jones, Julia E Prier, et al.
Modern Rheumatology|January 13, 2025
Disease activity and glucocorticoid tapering patterns in Japanese patients with systemic lupus erythematosus treated with anifrolumab: Post hoc analysis of the Japanese subpopulation of the TULIP-2 studyYoshiya Tanaka, Tatsuya Atsumi, Masato Okada, et al.
Pageof 25